More on CMMB
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.29 |
|
|||
| Open | $1.27 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $1.35 | ||||
| Day Low | $1.26 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 9,080 | ||||
- Form 6-K Chemomab Therapeutics For: Sep 30
- Chemomab Therapeutics to Present at H.C. Wainwright 28th Annual Global Investor Conference
- Form 6-K Chemomab Therapeutics For: Jun 30
- Chemomab Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update
- Form SCHEDULE 13G Chemomab Therapeutics Filed by: Touchstone Global Investments Pty Ltd
- Form SCHEDULE 13G/A Chemomab Therapeutics Filed by: Otto Erik
- Form SCHEDULE 13D Chemomab Therapeutics Filed by: HBM Healthcare Investments (Cayman) Ltd.
- Chemomab and Scipher Medicine agree to merge in $150M deal
- Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis
- Form 6-K Chemomab Therapeutics For: Jul 08
Entities mentioned with CMMB
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Irina Koffler | View Related Stories »
- Definitive Agreement | View Related Stories »
- ARK | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Maynard Um | View Related Stories »
- 13G | View Related Stories »
- Show More...
